Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Equity (2019 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Return on Equity for 7 consecutive years, with 0.3% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 2.0% year-over-year to 0.3%, compared with a TTM value of 0.3% through Dec 2025, up 2.0%, and an annual FY2025 reading of 0.29%, up 2.0% over the prior year.
  • Return on Equity was 0.3% for Q4 2025 at Arcturus Therapeutics Holdings, down from 0.29% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.38% in Q1 2023 and bottomed at 0.95% in Q1 2022.
  • Average Return on Equity over 5 years is 0.33%, with a median of 0.3% recorded in 2025.
  • The sharpest move saw Return on Equity skyrocketed 133bps in 2023, then crashed -77bps in 2024.
  • Year by year, Return on Equity stood at 0.83% in 2021, then skyrocketed by 106bps to 0.05% in 2022, then crashed by -310bps to 0.11% in 2023, then plummeted by -203bps to 0.32% in 2024, then grew by 7bps to 0.3% in 2025.
  • Business Quant data shows Return on Equity for ARCT at 0.3% in Q4 2025, 0.29% in Q3 2025, and 0.26% in Q2 2025.